Clinical Trials Identifier: NCT06075667 Trial Name: A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS) Trial Sponsor: Eli Lilly and Company What is the aim of the study
Taurine Amino acid that assists cellular hydration and metabolism
Neither peptide is FDA-approved
At baseline, there were no statistically significant differences between the groups with respect to age, sex, diagnosis, psychiatric symptoms, weight, height, BMI, waist circumference, fasting plasma glucose, lipids and C-reactive protein, except for HbA1c (Table 1)
This is actually useful information because it means dose adjustment is a viable management strategy
Studies in the model organism Caenorhabditis elegans have demonstrated that different FOXO isoformsparticularly DAF-16Aexert a significant influence on lifespan extension by activating or repressing specific genes such as gst-20 and srr-4, which either promote or inhibit longevity-associated mechanisms